The Current Ratio as of December 2025 (TTM) for Viking Therapeutics, Inc. (VKTX) is 28.34

According to Viking Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 28.34. This represents a change of -13.82% compared to the average of 32.88 of the last 4 quarters.

Viking Therapeutics, Inc. (VKTX) Historical Current Ratio (quarterly & annually)

How has VKTX Current Ratio performed in the past?

The mean historical Current Ratio of Viking Therapeutics, Inc. over the last ten years is 22.56. The current 28.34 Current Ratio has changed 12.46% with respect to the historical average. Over the past ten years (40 quarters), VKTX's Current Ratio was at its highest in in the December 2018 quarter at 66.40. The Current Ratio was at its lowest in in the September 2017 quarter at 1.20.

Viking Therapeutics, Inc. (VKTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Viking Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Viking Therapeutics, Inc. (VKTX) Average Current Ratio

How has VKTX Current Ratio performed in the past?

The current Current Ratio of Viking Therapeutics, Inc. (VKTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Viking Therapeutics, Inc. (VKTX) Current Ratio vs. Peers

How is VKTX’s Current Ratio compared to its peers?

Viking Therapeutics, Inc.’s Current Ratio is greater than Crinetics Pharmaceuticals, Inc. (15.12), greater than Kymera Therapeutics, Inc. (7.38), greater than Immunovant, Inc. (9.07), greater than NewAmsterdam Pharma Company N.V. (12.57), greater than Praxis Precision Medicines, Inc. (6.31), greater than Akero Therapeutics, Inc. (12.66), greater than Soleno Therapeutics, Inc. (16.08), greater than ASCENTAGE PHARMA GROUP INTERNATIONAL (1.54), greater than ACADIA Pharmaceuticals Inc. (2.91), greater than Ligand Pharmaceuticals Incorporated (24.69),

Build a custom stock screener for Viking Therapeutics, Inc. (VKTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Viking Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Viking Therapeutics, Inc. (VKTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Viking Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.